These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4910641)

  • 1. Long-lasting antituberculous activity of derivatives of 2-styrylquinoline.
    Pansy F; Jambor WP; Gadebusch HH; Donovick R
    Am Rev Respir Dis; 1970 May; 101(5):770-2. PubMed ID: 4910641
    [No Abstract]   [Full Text] [Related]  

  • 2. Microwave-assisted Synthesis of 2-Styrylquinoline-4-carboxylic Acids as Antitubercular Agents.
    Muscia GC; Asis SE; Buldain GY
    Med Chem; 2017; 13(5):448-452. PubMed ID: 27585570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antitubercular effect of capreomycin in vitro].
    Janowiec M
    Gruzlica; 1969 Jul; 37(7):629-35. PubMed ID: 4981783
    [No Abstract]   [Full Text] [Related]  

  • 4. [Microbacterial resistance to antibiotic preparations].
    Savchenko PIu
    Mikrobiol Zh; 1970; 32(3):376-82. PubMed ID: 4996138
    [No Abstract]   [Full Text] [Related]  

  • 5. [Sensivity of Mycobacterium kansaii and Mycobacterium marinum to different antituberculous drugs (author's transl)].
    García Rodríguez JA; Martín Luengo F; Sáenz González MC; Iglesias García J
    Med Clin (Barc); 1979 Feb; 72(4):145-8. PubMed ID: 431178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of once-weekly rifapentine and moxifloxacin regimens against Mycobacterium tuberculosis in mice.
    Lounis N; Bentoucha A; Truffot-Pernot C; Ji B; O'Brien RJ; Vernon A; Roscigno G; Grosset J
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3482-6. PubMed ID: 11709328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental studies on therapeutic effects of various combinations of antituberculosis drugs. II. Comparison of various regimens in treatment of experimental mouse tuberculosis infected with SM- and INH-resistant Schacht strain.
    Hokama S
    Jpn J Tuberc; 1967 Jul; 14(1):45-54. PubMed ID: 4295381
    [No Abstract]   [Full Text] [Related]  

  • 8. [The rational basis for the treatment of tuberculosis].
    Favez G
    Schweiz Med Wochenschr; 1971 Feb; 101(6):203-7. PubMed ID: 5563154
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro susceptibility of Mycobacterium bovis against moxifloxacin.
    Weiss T; Schönfeld N; Bettermann G; Blum TG; Kollmeier J; Mauch H; Bauer TT; Rüssmann H
    Int J Tuberc Lung Dis; 2012 Nov; 16(11):1562. PubMed ID: 23044455
    [No Abstract]   [Full Text] [Related]  

  • 10. [New combinations of drugs for the treatment of drug-resistant tuberculosis].
    Schmelev NA
    Bull Int Union Tuberc; 1968 Dec; 41():192-3. PubMed ID: 5710248
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experimental study of 2d order tuberculostatic preparations in Mycobacterium bovis resistance to isoniazid or streptomycin (based on the data from a morphological study)].
    Golyshevskaia VI; El'shanskaia MP
    Farmakol Toksikol; 1975; 38(2):222-4. PubMed ID: 776650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modern treatment of tuberculosis.
    Dutt AK; Stead WW
    Compr Ther; 1982 Sep; 8(9):19-28. PubMed ID: 7140206
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of DNA-tropic substances used jointly with tuberculostatic preparations on the development of drug resistance in Mycobacterium tuberculosis].
    Il'ina TB; Vishnevskiĭ BI
    Probl Tuberk; 1980 May; (5):67-70. PubMed ID: 6770368
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intermittent long-term cheomotherapy in experimental tuberculosis of the mouse].
    Grumbach F
    Bull Int Union Tuberc; 1968 Dec; 41():303-8. PubMed ID: 5710255
    [No Abstract]   [Full Text] [Related]  

  • 15. [Discrepancy between drug resistance of mycobacterium tuberculosis determined in vitro and in vivo].
    Belogurova VP; Gorislavets II; Ivanitskaia NN
    Probl Tuberk; 1971; 49(6):76-80. PubMed ID: 5000746
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on atypical mycobacteria. X. Experimental approach to the etiology of atypical mycobacteriosis.
    Ogawa T; Motomura K
    Kekkaku; 1971 Sep; 46(9):365-70. PubMed ID: 5122006
    [No Abstract]   [Full Text] [Related]  

  • 17. Experimental studies on therapeutic effects of various combinations of antituberculosis drugs. I. Comparison of various regimens in treatment of experimental mouse tuberculosis infected with drug-susceptible mycobacteria.
    Hokama S
    Jpn J Tuberc; 1967 Jul; 14(1):29-44. PubMed ID: 5300097
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sodium metabisulfite inhibition of the reaction between isoniazid and streptomycin in solution].
    Aleksandrova AE; Moldaver BL; Borisova OA; Vishnevskiĭ BI; Il'ina TB
    Probl Tuberk; 1983 Aug; (8):54-7. PubMed ID: 6356127
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of susceptibility of Mycobacterium bovis to antituberculous drugs by radiometric BACTEC 460TB system.
    Cavirani S; Fanti F; Benecchi M; Calderaro A; Taddei S; Arcangeletti C; Medici MC; Dettori G; Chezzi C
    New Microbiol; 2003 Apr; 26(2):181-6. PubMed ID: 12737201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of antibacterial preparations incorporated into liposomes in the treatment of experimental tuberculosis].
    Kurunov IuN; Nikolin VP; Kaledin VI; Matienko NA; Budker VG
    Probl Tuberk; 1982 Oct; (10):54-8. PubMed ID: 7178105
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.